Does SelectHealth Cover Lipitor?

At a glance
- Drug name / Lipitor (brand) and atorvastatin (generic)
- Generic availability / Yes, since 2011; widely available
- Typical SelectHealth formulary tier for generic / Tier 1 or Tier 2 (low-cost preferred)
- Typical SelectHealth formulary tier for brand Lipitor / Tier 3 or higher (non-preferred brand)
- Estimated generic copay / $5, $15 per 30-day supply (plan-dependent)
- Estimated brand copay without exception / $50, $200+ per 30-day supply
- Prior authorization required / Sometimes, for brand; rarely for generic
- Step therapy / Brand Lipitor may require trial of generic atorvastatin first
- How to check your specific plan / Log in to SelectHealth.com or call 1-800-538-5038
- Clinical guideline endorsement / ACC/AHA 2019 Guideline recommends high-intensity statins for most high-risk patients
What SelectHealth Covers for Lipitor and Atorvastatin
SelectHealth covers atorvastatin on virtually all of its commercial, Medicare Advantage, and Medicaid (Select Health of South Carolina and SelectHealth Utah/Idaho) plans. The generic version sits on a preferred low-cost tier, while brand-name Lipitor is placed on a non-preferred or specialty tier depending on the specific plan design.
Understanding the difference between brand and generic coverage is the first step to avoiding a surprise at the pharmacy counter.
Generic Atorvastatin vs. Brand Lipitor: What the Formulary Says
Pfizer's patent on Lipitor expired in November 2011. Since then, the FDA has approved more than a dozen generic atorvastatin manufacturers. The FDA confirmed therapeutic equivalence (AB-rated) between these generics and brand Lipitor, meaning they contain the same active ingredient at the same dose and are absorbed the same way. [1]
SelectHealth, like most U.S. Commercial insurers, places AB-rated generics on Tier 1 or Tier 2 of its drug formulary. Brand Lipitor, if it appears on the formulary at all, typically lands on Tier 3 (non-preferred brand) or Tier 4 (non-preferred brand with higher cost-sharing).
Most SelectHealth commercial members pay $0, $15 for a 30-day generic atorvastatin supply when using an in-network pharmacy. Members on Medicare Advantage SelectHealth plans generally see Tier 1 generics at $0, $5 in the coverage phase.
Step Therapy and Prior Authorization
Some SelectHealth plans impose step therapy on brand Lipitor. Step therapy means you must try the generic first. If your prescriber writes for brand Lipitor without documenting a clinical reason, the pharmacy may substitute the generic automatically, or you may receive a rejection requiring your doctor to submit a prior authorization (PA).
For generic atorvastatin, PA is rarely required. The drug is on the preferred formulary and is considered a first-line cardiovascular medication by every major cardiology guideline.
The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease states: "In adults 40 to 75 years of age with LDL-C 70 to 189 mg/dL and a 10-year atherosclerotic cardiovascular disease risk of 7.5% or greater, clinicians should initiate statin therapy." [2] Generic atorvastatin 10 mg, 20 mg, 40 mg, and 80 mg tablets are the most commonly prescribed agents fulfilling that recommendation.
Why the Generic Almost Always Wins on Cost
Atorvastatin is the best-selling statin worldwide by prescription volume. The cardiovascular outcomes data supporting it are among the most replicated in medicine.
The ASCOT-LLA Trial: The Evidence Base for Atorvastatin
The Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm (ASCOT-LLA, N=10,305) tested atorvastatin 10 mg versus placebo in hypertensive patients with a baseline LDL above 130 mg/dL. The trial was stopped early at a median 3.3 years because atorvastatin reduced the primary endpoint (non-fatal MI plus fatal coronary heart disease) by 36% (hazard ratio 0.64, 95% CI 0.50 to 0.83, P<0.001). [3]
Because that trial used the drug that is now generic atorvastatin, insurers have no clinical reason to prefer the brand formulation. Cost-effectiveness analyses consistently show the generic delivers the same outcomes at roughly one-tenth of the brand cost.
The TNT Trial: Higher-Dose Atorvastatin in Stable CHD
The Treating to New Targets (TNT) trial (N=10,001) compared atorvastatin 80 mg to atorvastatin 10 mg in patients with stable coronary heart disease. At 4.9 years, the 80 mg arm showed a 22% relative reduction in major cardiovascular events (P<0.001). [4] Both doses are available generically, which is another reason SelectHealth formularies place atorvastatin at the lowest cost tier.
What You Actually Pay at the Pharmacy
Out-of-pocket costs vary by plan year, deductible status, and whether you have met your out-of-pocket maximum. Here is a realistic cost range for SelectHealth members in 2025:
| Drug | Tier | Typical 30-day Copay | Notes | |---|---|---|---| | Atorvastatin 10 to 80 mg (generic) | Tier 1 | $0, $15 | Most common scenario | | Atorvastatin 10 to 80 mg (generic) | Tier 2 | $10, $30 | Some HDHP plans | | Lipitor 10 to 80 mg (brand) | Tier 3 | $45, $80 | Non-preferred brand | | Lipitor 10 to 80 mg (brand) | Tier 4 | $80, $200+ | Non-formulary or specialty tier |
These ranges reflect SelectHealth's published Summary of Benefits documents and standard commercial plan cost-sharing structures. Always verify your specific plan at SelectHealth.com or by calling member services.
How to Confirm Lipitor or Atorvastatin Coverage on Your Specific Plan
SelectHealth serves members across Utah, Idaho, and Nevada (commercial) and South Carolina (Medicaid), with somewhat different formularies in each market. Checking your individual coverage takes about five minutes.
Using the SelectHealth Online Formulary Tool
- Go to SelectHealth.com and log in to your member account.
- Click "Benefits and Coverage," then "Prescription Drug Coverage."
- Enter "atorvastatin" or "Lipitor" in the drug search field.
- Select your dose (10 mg, 20 mg, 40 mg, or 80 mg).
- The tool shows your tier, estimated copay, and any PA or step-therapy requirements attached to that drug.
The National Drug Code (NDC) for the generic may differ across manufacturers, but your formulary search will display coverage for the generic class regardless of manufacturer.
Calling SelectHealth Member Services
Member services can confirm coverage, walk you through the PA process, and tell you which in-network pharmacies have the lowest dispensing fee. The main line is 1-800-538-5038. Have your member ID card available.
Asking Your Pharmacist
Retail pharmacists at Walgreens, CVS, Smith's (Kroger), and Costco all have real-time adjudication tools. They can run a test claim before you fill the prescription to show your exact out-of-pocket cost that day.
When Brand Lipitor Might Be Covered at the Same Cost as Generic
There are a small number of clinical situations where SelectHealth may approve brand Lipitor at the generic cost tier.
Medical Necessity Exception
If a patient has a documented adverse reaction to fillers or dyes used in a specific generic atorvastatin manufacturer's tablet, a prescriber can file a formulary exception. The exception request must include:
- A clinical note documenting the adverse reaction.
- The specific generic lot or manufacturer that caused it.
- A statement that the brand formulation is medically necessary.
SelectHealth's standard review timeline is 72 hours for non-urgent requests and 24 hours for urgent requests, consistent with CMS Part D timelines. [5]
Manufacturer Coupon or Pfizer Patient Assistance
Pfizer offers a patient assistance program called Pfizer RxPathways. Eligible patients with commercial insurance who still face high brand-name costs may receive Lipitor at reduced cost or free through this program. This is separate from SelectHealth coverage and does not affect your formulary tier.
Note: Manufacturer coupons generally cannot be used with Medicare Part D plans due to federal anti-kickback statute restrictions. This restriction does not apply to commercial (non-Medicare) plans.
The Clinical Case for Atorvastatin: Why Statins Matter
Approximately 93 million U.S. Adults have total cholesterol above 200 mg/dL, according to CDC surveillance data. [6] High LDL-cholesterol is the primary modifiable driver of atherosclerotic cardiovascular disease (ASCVD), which remains the leading cause of death in the United States.
How Atorvastatin Works
Atorvastatin is a hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. It blocks the rate-limiting enzyme in the liver's cholesterol synthesis pathway, which triggers upregulation of LDL receptors and accelerates LDL clearance from the bloodstream. At 80 mg daily, atorvastatin can reduce LDL-C by 50 to 60% from baseline. [7]
High-Intensity vs. Moderate-Intensity Statin Dosing
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol classifies statins by intensity:
- High-intensity: Atorvastatin 40 to 80 mg (reduces LDL-C by at least 50%)
- Moderate-intensity: Atorvastatin 10 to 20 mg (reduces LDL-C by 30 to 49%)
- Low-intensity: Not applicable for atorvastatin at any approved dose
The guideline states: "High-intensity statin therapy should be used for secondary prevention in patients with clinical ASCVD." [8] Generic atorvastatin fulfills this recommendation at every dose level, from 10 mg to 80 mg.
Side Effects and Monitoring
Statin-associated muscle symptoms (SAMS) occur in approximately 5 to 10% of patients in randomized controlled trials, though observational data suggest rates up to 20% in clinical practice. [9] The SAMSON trial (N=200) used a blinded, n-of-1 design and found that 90% of symptom burden attributed to statins was actually the nocebo effect, with only 9% of symptoms being genuinely drug-caused. [10]
Routine monitoring includes:
- A baseline lipid panel before starting therapy.
- A fasting lipid panel 4 to 12 weeks after dose initiation or change.
- Liver enzyme testing if symptoms of hepatotoxicity develop (routine baseline ALT is no longer recommended per 2018 guidelines).
- Creatine kinase (CK) testing only if muscle symptoms appear.
What Happens If SelectHealth Denies Coverage for Lipitor
A denial is not the end of the road. Three distinct appeal pathways exist.
Internal Appeal
You or your prescriber can file an internal appeal within 180 days of the denial. SelectHealth must respond within 30 days for standard requests or 72 hours for expedited requests. The appeal should include clinical documentation explaining why the brand is medically necessary or why the generic is not appropriate.
External Appeal
If the internal appeal fails, you can request an independent external review through the Utah Insurance Department (or your state's equivalent). External reviewers are independent of SelectHealth and are required to follow state and federal timelines.
Grievance and the Office of Patient Advocate
For Medicare Advantage SelectHealth plans, the CMS Medicare Part D appeals process applies. CMS data show that enrollees who appeal Part D denials win approximately 75% of the time at the Independent Review Entity (IRE) stage. [5]
Alternatives to Lipitor That SelectHealth Covers
If atorvastatin does not control your LDL or causes side effects, SelectHealth formularies generally include these options at low cost:
| Drug | Class | Typical LDL Reduction | SelectHealth Tier | |---|---|---|---| | Rosuvastatin (generic Crestor) | Statin | 38 to 55% | Tier 1 to 2 | | Simvastatin (generic Zocor) | Statin | 26 to 47% | Tier 1 | | Pravastatin (generic Pravachol) | Statin | 20 to 35% | Tier 1 | | Ezetimibe (generic Zetia) | Cholesterol absorption inhibitor | 13 to 20% add-on | Tier 1 to 2 | | Rosuvastatin/ezetimibe (Roszet) | Combo | 45 to 63% | Tier 2 to 3 | | Bempedoic acid (Nexletol) | ACL inhibitor | 18 to 28% | Tier 3 to 4 (PA likely) | | Evolocumab (Repatha) | PCSK9 inhibitor | 58 to 71% | Specialty (PA required) |
PCSK9 inhibitors like evolocumab and alirocumab are the most potent LDL-lowering agents available. In the FOURIER trial (N=27,564), evolocumab added to statin therapy reduced LDL-C by 59% and reduced the composite MACE endpoint by 15% (HR 0.85, 95% CI 0.79 to 0.92, P<0.001). [11] SelectHealth covers these agents, but prior authorization and step therapy through high-dose statin plus ezetimibe are standard requirements.
Practical Tips for Reducing Your Atorvastatin Cost With SelectHealth
The following five-step framework is designed specifically for SelectHealth members trying to minimize out-of-pocket costs on statin therapy.
Step 1. Confirm generic substitution is active on your prescription. Ask your prescriber to write "atorvastatin" (not "Lipitor") or add "DAW-0" (dispense as written: substitution permitted) to any existing Lipitor prescription.
Step 2. Use a 90-day mail-order supply. SelectHealth partners with a mail-order pharmacy that typically charges two months' copay for a 90-day supply, saving approximately 33% per fill.
Step 3. Compare GoodRx or Cost Plus Drugs cash prices. On days when your deductible is not yet met, Mark Cuban's Cost Plus Drugs lists atorvastatin 40 mg (90 tablets) for under $15. This price may beat your insurance cost-sharing in early plan year months.
Step 4. Request a formulary exception before filling brand. If your doctor believes brand Lipitor is clinically necessary, get the exception approved before presenting the prescription at the pharmacy.
Step 5. Check HRSA-funded health centers. Federally Qualified Health Centers (FQHCs) participate in the 340B drug pricing program, which can dramatically reduce statin costs for eligible patients even if they have insurance.
Does Your SelectHealth Plan Type Affect Lipitor Coverage?
SelectHealth offers several distinct plan types, and formulary placement can differ between them.
SelectHealth Commercial (HMO and PPO)
Commercial plans sold through employers or the Utah health exchange follow SelectHealth's standard commercial formulary. Generic atorvastatin is Tier 1 on nearly all of these plans. Brand Lipitor is Tier 3.
SelectHealth Medicare Advantage (HMO-POS and PPO)
Medicare Advantage plans use a CMS-approved formulary. CMS requires all Part D plan sponsors to cover at least two drugs per drug class. Generic atorvastatin satisfies this requirement on every SelectHealth Medicare Advantage plan reviewed. The 2025 CMS Part D Inflation Reduction Act changes cap monthly out-of-pocket costs for Medicare Part D at $2,000 annually, which benefits high-cost drug users.
SelectHealth Medicaid (Select Health of South Carolina)
South Carolina Medicaid uses a state-administered preferred drug list (PDL). Generic atorvastatin is a preferred drug on South Carolina's Medicaid PDL. Members typically pay $0, $3 per prescription.
SelectHealth Individual and Family Plans (ACA Marketplace)
ACA-compliant plans must cover preventive medications, including statins prescribed for primary prevention, with zero cost-sharing under the USPSTF Grade B recommendation. The USPSTF recommends prescribing a statin for primary prevention of CVD events in adults aged 40 to 75 who have one or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year cardiovascular event risk of 10% or greater. [12] If your atorvastatin is prescribed under this preventive care designation, you may owe $0 regardless of your deductible status.
Frequently asked questions
›Does SelectHealth cover Lipitor?
›How much does atorvastatin cost with SelectHealth?
›Does SelectHealth require prior authorization for Lipitor?
›Is generic atorvastatin the same as Lipitor?
›What tier is Lipitor on SelectHealth?
›Can I appeal if SelectHealth denies Lipitor coverage?
›Does SelectHealth cover statins at no cost for preventive care?
›What is the cheapest statin covered by SelectHealth?
›Does SelectHealth cover Crestor (rosuvastatin)?
›How do I get a formulary exception for brand Lipitor on SelectHealth?
References
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Atorvastatin calcium entry. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177, e232. https://pubmed.ncbi.nlm.nih.gov/30894318/
- Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA). Lancet. 2003;361(9364):1149 to 1158. https://pubmed.ncbi.nlm.nih.gov/12686036/
- LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease (TNT). N Engl J Med. 2005;352(14):1425 to 1435. https://pubmed.ncbi.nlm.nih.gov/15755765/
- Centers for Medicare and Medicaid Services. Part D Appeals and Grievances. https://www.cms.gov/medicare/appeals-and-grievances/part-d-appeals
- Centers for Disease Control and Prevention. Cholesterol Facts. https://www.cdc.gov/cholesterol/facts.htm
- Stein EA, Ballantyne CM, Windler E, et al. Efficacy and tolerability of fluvastatin XL 80 mg alone, atorvastatin 10 mg alone, and the combination of fluvastatin XL 80 mg and atorvastatin 10 mg in patients with a combined hyperlipidemia. Am J Cardiol. 2003;91(6):667 to 672. https://pubmed.ncbi.nlm.nih.gov/12633793/
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082, e1143. https://pubmed.ncbi.nlm.nih.gov/30586774/
- Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy, European Atherosclerosis Society Consensus Panel Statement. Eur Heart J. 2015;36(17):1012 to 1022. https://pubmed.ncbi.nlm.nih.gov/25694464/
- Wood FA, Howard JP, Finegold JA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects (SAMSON). N Engl J Med. 2020;383(22):2182 to 2184. https://pubmed.ncbi.nlm.nih.gov/33196154/
- Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER). N Engl J Med. 2017;376(18):1713 to 1722. https://pubmed.ncbi.nlm.nih.gov/28304224/
- U.S. Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease Events in Adults: Preventive Medication. USPSTF Recommendation Statement. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication